Latest Inflammatory breast cancer Stories
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer.
Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have discovered a new way to model human breast cancer that could lead to new tools for predicting which breast cancers will spread and new ways to test drugs that may stop its spread.
Obese women develop breast cancer at a younger age than other women.
IRVINE, California and AMSTERDAM, August 10, 2011 /PRNewswire/ -- Agendia, a commercial-stage molecular cancer diagnostics company, today announced that the 12th St.
ATLANTA, July 5, 2011 /PRNewswire/ -- Earlier this year, the Food and Drug Administration (FDA) reviewed a possible link between breast implants and a rare type of cancer (anaplastic large cell lymphoma, or ALCL).
Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict a breast cancer patients' risk of cancer recurrence.
Recent research indicates medications such as Tamoxifen or Raloxifene considerably reduce the risk of developing breast cancer in post-menopausal women.
Tamoxifen, taken by women as a preventive measure against breast cancer, sufficiently compensates for its side effects in post-menopausal women under the age of 55 years, according to this study.
- totally perplexed and mixed up.